Isracann Biosciences Inc.
ISCNF · OTC
8/31/2022 | 5/31/2022 | 2/28/2022 | 11/30/2021 | |
|---|---|---|---|---|
| Market Cap | $7,988 | $9,719 | $13,882 | $11,835 |
| - Cash | $198 | $214 | $311 | $827 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $7,790 | $9,505 | $13,572 | $11,008 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$10 | -$10 | -$10 | -$10 |
| % Margin | – | – | – | – |
| EBITDA | -$306 | -$2,720 | -$610 | -$864 |
| % Margin | – | – | – | – |
| Net Income | -$316 | -$2,730 | -$620 | -$874 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.002 | -0.017 | -0.004 | -0.006 |
| % Growth | 88.4% | -309.5% | 30% | – |
| Operating Cash Flow | -$163 | -$215 | -$522 | -$575 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$163 | -$215 | -$522 | -$575 |